These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21091079)

  • 21. A novel mechanism for vascular insulin resistance in normotensive young SHRs: hypoadiponectinemia and resultant APPL1 downregulation.
    Xing W; Yan W; Liu P; Ji L; Li Y; Sun L; Tao L; Zhang H; Gao F
    Hypertension; 2013 May; 61(5):1028-35. PubMed ID: 23478100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.
    Waragai M; Ho G; Takamatsu Y; Shimizu Y; Sugino H; Sugama S; Takenouchi T; Masliah E; Hashimoto M
    Drug Discov Today; 2018 Jun; 23(6):1305-1311. PubMed ID: 29747002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of adiponectin in cardiovascular disease.
    Shibata R; Murohara T; Ouchi N
    Curr Med Chem; 2012; 19(32):5459-66. PubMed ID: 22876923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin receptors: a review of their structure, function and how they work.
    Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
    Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice.
    Ma Y; Liu Y; Liu S; Qu Y; Wang R; Xia C; Pei H; Lian K; Yin T; Lu X; Sun L; Yang L; Cao Y; Lau WB; Gao E; Wang H; Tao L
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E447-55. PubMed ID: 21586697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
    Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological role of adiponectin in different tissues: a review.
    Esmaili S; Hemmati M; Karamian M
    Arch Physiol Biochem; 2020 Feb; 126(1):67-73. PubMed ID: 30451000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotection of ischemic preconditioning in rats involves upregulating adiponectin.
    Wang H; Wu W; Duan J; Ma M; Kong W; Ke Y; Li G; Zheng J
    J Mol Endocrinol; 2017 May; 58(4):155-165. PubMed ID: 28219936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potential.
    Yu XH; Zhang DW; Zheng XL; Tang CK
    Atherosclerosis; 2018 Sep; 276():109-116. PubMed ID: 30056359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin action from head to toe.
    Brochu-Gaudreau K; Rehfeldt C; Blouin R; Bordignon V; Murphy BD; Palin MF
    Endocrine; 2010 Feb; 37(1):11-32. PubMed ID: 20963555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Back to the heart: the protective role of adiponectin.
    Caselli C; D'Amico A; Cabiati M; Prescimone T; Del Ry S; Giannessi D
    Pharmacol Res; 2014 Apr; 82():9-20. PubMed ID: 24657240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling.
    Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG
    Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin, an unlocking adipocytokine.
    Sun Y; Xun K; Wang C; Zhao H; Bi H; Chen X; Wang Y
    Cardiovasc Ther; 2009; 27(1):59-75. PubMed ID: 19207481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
    Gable DR; Hurel SJ; Humphries SE
    Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
    Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
    Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin and Cognitive Decline.
    Rizzo MR; Fasano R; Paolisso G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes.
    Nacci C; Leo V; De Benedictis L; Potenza MA; Sgarra L; De Salvia MA; Quon MJ; Montagnani M
    Vascul Pharmacol; 2016 Dec; 87():83-91. PubMed ID: 27565410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of adiponectin signaling in metabolic syndrome and cancer.
    Scheid MP; Sweeney G
    Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response.
    Niemann B; Li L; Siegler D; Siegler BH; Knapp F; Hanna J; Aslam M; Kracht M; Schulz R; Rohrbach S
    Cells; 2020 May; 9(5):. PubMed ID: 32429302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.